65 related articles for article (PubMed ID: 20578193)
1. Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?
Hillegass WB
Catheter Cardiovasc Interv; 2010 Jul; 76(1):58-9. PubMed ID: 20578193
[No Abstract] [Full Text] [Related]
2. Stenting unprotected left main: the outcome is not always favorable.
Colombo A
Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
[No Abstract] [Full Text] [Related]
3. Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry.
Akin I; Bufe A; Eckardt L; Reinecke H; Richardt G; Kuck KH; Senges J; Schneider S; Nienaber CA;
Catheter Cardiovasc Interv; 2010 Jul; 76(1):50-7. PubMed ID: 20578192
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of the First In Man experience with everolimus-eluting stents.
Kimmelstiel C
Catheter Cardiovasc Interv; 2010 Jun; 75(7):1004-5. PubMed ID: 20517960
[No Abstract] [Full Text] [Related]
5. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
Morrison DA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
[No Abstract] [Full Text] [Related]
6. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
7. Multivessel disease in diabetics: does DES level the field?
Hillegass W
Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
[No Abstract] [Full Text] [Related]
8. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
Jensen LO; Tilsted HH; Thayssen P; Kaltoft A; Maeng M; Lassen JF; Hansen KN; Madsen M; Ravkilde J; Johnsen SP; Sørensen HT; Thuesen L
EuroIntervention; 2010 Apr; 5(8):898-905. PubMed ID: 20542774
[TBL] [Abstract][Full Text] [Related]
9. Off-label use and the spectre of drug-eluting stent thrombosis.
Cook S; Wenaweser P
Circ Cardiovasc Interv; 2009 Aug; 2(4):273-6. PubMed ID: 20031728
[No Abstract] [Full Text] [Related]
10. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
[TBL] [Abstract][Full Text] [Related]
11. The long-term results of the "Endeavor" stent.
Kornovski R
Catheter Cardiovasc Interv; 2009 Dec; 74(7):996-9. PubMed ID: 19953512
[No Abstract] [Full Text] [Related]
12. Are we totally clear?
Morrison DA
Catheter Cardiovasc Interv; 2009 Dec; 74(7):987-8. PubMed ID: 19953511
[No Abstract] [Full Text] [Related]
13. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization?
Bailey SR
Catheter Cardiovasc Interv; 2008 Oct; 72(4):457-8. PubMed ID: 18819143
[No Abstract] [Full Text] [Related]
14. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
Wood FO; Saylors EK; Schneider JE; Jobe RL; Mann JT
Catheter Cardiovasc Interv; 2008 Mar; 71(4):533-8. PubMed ID: 18307224
[TBL] [Abstract][Full Text] [Related]
15. Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
Byrne RA; Kastrati A
Catheter Cardiovasc Interv; 2008 Dec; 72(7):944-9. PubMed ID: 19021280
[TBL] [Abstract][Full Text] [Related]
16. More openness and a little less strut: two good ideas for stents and the people who implant them.
Morrison DA
Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
[No Abstract] [Full Text] [Related]
17. Another small step for small vessels.
Morrison DA
Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
[No Abstract] [Full Text] [Related]
18. Long-term paclitaxel-eluting stent outcomes in elderly patients.
Forman DE; Cox DA; Ellis SG; Lasala JM; Ormiston JA; Stone GW; Turco MA; Wei JY; Joshi AA; Dawkins KD; Baim DS
Circ Cardiovasc Interv; 2009 Jun; 2(3):178-87. PubMed ID: 20031714
[TBL] [Abstract][Full Text] [Related]
19. Inflation time and drug-eluting stent: the longer, the better..
Bertrand OF
Catheter Cardiovasc Interv; 2009 Feb; 73(2):212-3. PubMed ID: 19156881
[No Abstract] [Full Text] [Related]
20. SES for AMI: moving in the right direction.
Vetrovec GW
Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
